![3-Pyridinecarboxylic acid, 2-[(4-chlorophenyl)amino]-](https://static.cymitquimica.com/cas-image/157064-3-pyridinecarboxylic-acid-2-4-chlorophenyl-amino.png)
CAS: 16344-26-6 - 3-Pyridinecarboxylic acid, 2-[(4-chlorophenyl)amino]-
Fórmula:C12H9ClN2O2
| Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
|---|---|---|---|---|
 | 3-Pyridinecarboxylic acid, 2-[(4-chlorophenyl)amino]- REF: IN-DA001U4MCAS: 16344-26-6 | 97% | A consultar | Ter 10 Dez 24 |
 | 2-[(4-Chlorophenyl)amino]nicotinic acid REF: 3D-FC136121CAS: 16344-26-6 | Min. 95% | 145,00 €~865,00 € | Qui 19 Dez 24 |
 | DHODH-IN-17 REF: TM-T60364CAS: 16344-26-6 | 100% - 100% | 69,00 €~917,00 € | Ter 28 Jan 25 |
![3-Pyridinecarboxylic acid, 2-[(4-chlorophenyl)amino]-](https://static.cymitquimica.com/products/IN/thumb/DA001U4M.jpg)
3-Pyridinecarboxylic acid, 2-[(4-chlorophenyl)amino]-
CAS:16344-26-6
Fórmula:
C12H9ClN2O2
Pureza:
97%
Peso molecular:
248.6651
Ref: IN-DA001U4M
| 5mg | 109,00 € | ||
| 10mg | 162,00 € |
Entrega estimada em Estados Unidos, Terça-feira 10 de Dezembro de 2024
![2-[(4-Chlorophenyl)amino]nicotinic acid](https://static.cymitquimica.com/products/3D/thumb/FC136121.jpg)
2-[(4-Chlorophenyl)amino]nicotinic acid
CAS:16344-26-6
2-[(4-Chlorophenyl)amino]nicotinic acid is a fine chemical that is useful for the production of a variety …
Fórmula:
C12H9ClN2O2
Pureza:
Min. 95%
Cor e Forma:
Brown Powder
Peso molecular:
248.66 g/mol
Ref: 3D-FC136121
| 1g | 538,00 € | ||
| 2g | 865,00 € | ||
| 100mg | 145,00 € | ||
| 250mg | 261,00 € | ||
| 500mg | 363,00 € |
Entrega estimada em Estados Unidos, Quinta-feira 19 de Dezembro de 2024
DHODH-IN-17
CAS:16344-26-6
DHODH-IN-17 is a human DHODH inhibitor with an IC50 of 0.40 μM.
Fórmula:
C12H9ClN2O2
Pureza:
100% - 100%
Cor e Forma:
Liquid
Peso molecular:
248.67
Ref: TM-T60364
| 5mg | 69,00 € | ||
| 10mg | 102,00 € | ||
| 25mg | 198,00 € | ||
| 50mg | 296,00 € | ||
| 100mg | 439,00 € | ||
| 500mg | 917,00 € | ||
| 1mL*10mM (DMSO) | 74,00 € |
Entrega estimada em Estados Unidos, Terça-feira 28 de Janeiro de 2025
